You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review

 

Online download statistics by month:

Online download statistics by month: January 2024 to July 2025

AbstractFullPdf
Jan 2024541543187
Feb 202418318481
Mar 202414214469
Apr 202414014243
May 202414414656
Jun 202415916474
Jul 202416516766
Aug 202410710847
Sep 202416717071
Oct 202416816870
Nov 202414615052
Dec 202417718170
Jan 202517617870
Feb 202519719968
Mar 202512812876
Apr 202515015067
May 202511611764
Jun 2025181181105
Jul 2025110
Total318832211336